|
|
||||||||
Infectious Diseases Section, Buffalo VA Medical Center, NY 14215.
Health care personnel who received the hepatitis B vaccine (Heptavax-BR, MSD) were followed for persistence of hepatitis B surface antibody (anti-HBs). Response occurred in 135/146 (92.5 percent) vaccinees. Loss of anti-HBs (less than 72 RIA units; 10 S/N) occurred in 35.9 percent during the 36-month surveillance. Stepwise discriminant analysis found age and magnitude of initial antibody level, but not weight-height index, to be predictive of antibody loss over the 36 months. Twenty-four of 27 employees (88.9 percent) who lost anti-HBs responded to a fourth vaccine dose. In contrast, three of eight initial non-responders (37.5 percent) developed antibody after a fourth vaccine dose.
This article has been cited by other articles:
![]() |
T. Lincoln, R. W. Tuthill, S. L. DePietro, M. J. Tocco, K. Keough, and T. J. Conklin Viral Hepatitis, Risk Behaviors, Aminotransferase Levels, and Screening Options at a County Correctional Center Journal of Correctional Health Care, October 1, 2006; 12(4): 249 - 261. [Abstract] [PDF] |
||||
![]() |
B. J. McMahon, D. L. Bruden, K. M. Petersen, L. R. Bulkow, A. J. Parkinson, O. Nainan, M. Khristova, C. Zanis, H. Peters, and H. S. Margolis Antibody Levels and Protection after Hepatitis B Vaccination: Results of a 15-Year Follow-up Ann Intern Med, March 1, 2005; 142(5): 333 - 341. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. E. Burns, D. Carroll, C. Ring, L. K. Harrison, and M. Drayson Stress, Coping, and Hepatitis B Antibody Status Psychosom Med, March 1, 2002; 64(2): 287 - 293. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |